Please assess the completion status of the following clinical trial:

Trial Title: Negative Pressure Wound Therapy for the Treatment of Chronic Pressure Wounds

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age \> 18 years~2. All chronic pressure wounds of the pelvic region except trochanteric wounds.~3. Chronic pressure wound defined as the presence of a pressure wound for \> 6 weeks and \< 6 months with no sign of improvement in healing~4. Wound size surface area \> 2cm2~5. Stage III-IV pressure ulcer according to the National Pressure Ulcer Advisory Panel (NPUAP)~6. No clinical signs of active infection at the wound site and currently not on antibiotics~7. Willingness to off-load or pressure redistribute ulcer~Exclusion Criteria:~1. Candidate for surgery in the next 12 weeks~2. A wound with necrotic tissue unable to tolerate debridement~3. Exposed blood vessels and/or organs within the wound~4. Chronic osteomyelitis (as determined by biopsy) or osteomyelitis that is not treatable by debridement and antibiotics~5. Non-enteric or unexplored fistulae~6. Wounds requiring hemostasis (i.e., that the flow of blood be stopped) for local bleeding~7. Alternate etiology for non-healing~8. Concomitant conditions that in the judgment of the investigator would make the subject inappropriate for entry to the study (e.g., malignancy in wound, malignancy less than 1-year disease free interval, previous or current irradiation, known immunodeficiency and/or major uncorrected medical disorders such as serious non-malignant disease, serious cardiovascular or pulmonary disease, lupus, inflammatory bowel disease, palliative care or sickle cell disease)~9. Poor nutritional status as determined by a Braden Scale Nutritional Assessment score of 2 or 1 with a serum albumin \< 25 g/L and hemoglobin \< 90 g/L~10. Currently taking medication that may interfere with wound healing (e.g., oral systemic steroids, immunosuppressive drugs, unfractionated heparin infusion)~11. Women who are currently pregnant or are breast feeding; or women of child bearing potential who are not currently taking adequate birth control~12. Participation in another investigative drug or device trial currently or within the last 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Standard Dressings
- 2 (Type: EXPERIMENTAL): Negative Pressure Wound Therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).